Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BetterLife FSHD: A Patient-driven Health and Research Platform

NCT07409142 is registered in ClinicalTrials.gov with FSHD Society as lead sponsor.

NCT NCT07409142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07409142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BetterLife FSHD: A Patient-driven Health and Research Platform
Lead sponsor
FSHD Society
Phase
Observational
Overall status
Recruiting
Start date
August 2, 2024
Completion date
January 31, 2060
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facioscapulohumeral muscular dystrophy, facioscapulohumeral muscular dystrophy (fshd), facioscapulohumeral muscular dystrophy 1, facioscapulohumeral muscular dystrophy 2, fsh, fsh muscular dystrophy, fshd, fshd - facioscapulohumeral muscular dystrophy, fshd1, fshd2, muscular dystrophy, facioscapulohumeral